Bellman, Jakob
Westerterp, Klaas
Wouters, Loek
Johannesson, Marit
Lundqvist, Niklas
Kullberg, Joel
Larsson, Christel
Gustafsson, Mikael
Pettersson, Stefan
Fridolfsson, Jonatan
Arvidsson, Daniel
Börjesson, Mats
Curiac, Dan
Jansson, John-Olov
Jansson, Per-Anders
Ohlsson, Claes
Funding for this research was provided by:
ALF-agreement (ALFGBG-965051, ALFGBG-965051, ALFGBG-965051)
Göteborgs Läkaresällskap (22/972547)
Stiftelsen Mary von Sydows, född Wijk, donationsfond (2024-139)
Knut och Alice Wallenbergs Stiftelse (KAW 2020.0230)
Torsten Söderbergs Stiftelse (MT3/20)
University of Gothenburg
Article History
Received: 5 February 2025
Accepted: 16 May 2025
First Online: 30 May 2025
Declarations
:
: The trial was approved by the Swedish Ethical Review Authority (registration number 2021–00095) and was conducted in accordance with the Declaration of Helsinki and the International Conference on Harmonization Guidelines (ICH) for Good Clinical Practice (GCP). All participants provided written informed consent before undertaking any study procedures.
: The authors declare no competing interests.